Abstract: An electrochemical hydrogen pump includes at least one hydrogen pump unit including an electrolyte membrane, an anode on one main surface of the electrolyte membrane, a cathode on the other main surface of the electrolyte membrane, an anode separator on the anode, and a cathode separator on the cathode, the at least one hydrogen pump unit transferring, to the cathode, hydrogen supplied to the anode and pressurizing the hydrogen, a first fixing member for preventing movement of the cathode separator in a direction in which the cathode separator is stacked, a first end plate on the anode separator at one end in the stacking direction, a second end plate on the cathode separator at the other end in the stacking direction, and a first gas flow channel through which hydrogen in the cathode is supplied to a first space between the second end plate and the cathode separator.

Abstract: The present invention provides: a marker for determining critical stage kidney disease by using an indicator value based on the amount of D-alanine in the blood or the amount of D-alanine and L-alanine therein; a blood analysis method which uses said marker for patients undergoing surgery or intensive care; and a blood analysis system for determining critical stage kidney disease in patients undergoing surgery or intensive care.

Abstract: The present invention pertains to a pharmaceutical composition for the prevention or treatment of kidney disease, an inflammation inhibitor for the kidneys, an inflammatory cell death inhibitor for the kidneys, or a food for the prevention or improvement of kidney disease, that include D-serine or a derivative thereof. In addition, the present invention pertains to the use of D-serine or a derivative thereof, for the production of a pharmaceutical composition for the prevention or treatment of kidney disease.

Abstract: The present invention pertains to a pharmaceutical composition for the prevention or treatment of kidney disease, a kidney inflammation inhibitor, an inflammatory cell death inhibitor for the kidneys, or a food for the prevention or improvement of kidney disease, that include D-alanine or a derivative thereof. In addition, the present invention pertains to the use of D-alanine or a derivative thereof, for the production of a pharmaceutical composition for the prevention or treatment of kidney disease.

Abstract: Recognition result of an objective recognized as a preceding vehicle is analyzed to judge whether this objective is correctly detected as a vehicle or not. A relative acceleration is calculated based on a relative speed corresponding to the objective when analysis result shows properness of this objective as a vehicle. The relative acceleration is set to 0 when analysis result shows improperness of the objective. An inter-vehicle control amount is corrected based on the obtained relative acceleration. The distance between the preceding vehicle and the controlled vehicle is controlled based on the corrected inter-vehicle control amount.

Abstract: A travel control system for a subject vehicle includes a radar device for detecting preceding vehicles with respect to the subject vehicle. A controlling device operates for detecting, among the detected preceding vehicles, an interested preceding vehicle which immediately precedes the subject vehicle, and for accelerating and decelerating the subject vehicle in response to a condition of the interested preceding vehicle. A relative speed calculating device operates for calculating a relative speed between the subject vehicle and a next-lane preceding vehicle among the detected preceding vehicles. The next-lane preceding vehicle is a preceding vehicle in a lane next to a lane where the subject vehicle exists. The controlling device also operates for executing one of (1) suppression of acceleration of the subject vehicle and (2) deceleration control of the subject vehicle when the relative speed calculated by the relative speed calculating device is smaller than a prescribed negative value.

Abstract: Recognition result of an objective recognized as a preceding vehicle is analyzed to judge whether this objective is correctly detected as a vehicle or not. A relative acceleration is calculated based on a relative speed corresponding to the objective when analysis result shows properness of this objective as a vehicle. The relative acceleration is set to 0 when analysis result shows improperness of the objective. An inter-vehicle control amount is corrected based on the obtained relative acceleration. The distance between the preceding vehicle and the controlled vehicle is controlled based on the corrected inter-vehicle control amount.

Abstract: An informing apparatus is designed for use with a cruise control system having at least one of a function of inter-vehicle control for enabling a present vehicle to follow a preceding vehicle and a function of constant-speed travel control for enabling the present vehicle to travel at a constant speed. In the informing apparatus, a determination is made as to whether or not a main switch is in its ON position. The main switch is designed for setting a state in which the cruise control system can start to operate. A determination is made as to whether or not a set switch is in its OFF position. The set switch is designed for commanding execution of cruise control. A speed of the present vehicle and a setting lower limit vehicle speed are indicated on a contradistinction basis when it is determined that the main switch is in its ON position while the set switch is in its OFF position. The setting lower limit vehicle speed denotes a lower limit of a vehicle speed range in which the cruise control is enabled.